This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Genentech, Inc., New York University. Active years: 1992-2003.
Location History:
- Riverdale, NY (US) (1992 - 1993)
- Bronx, NY (US) (1998 - 2003)
Company Filing History:
4 out of 3,288 
2 out of 1,726 
Years Active: 1992-2003
Title: The Innovations of Michael A. Davitz
Introduction
Michael A. Davitz is a notable inventor based in the Bronx, NY (US). He holds a total of 4 patents that reflect his contributions to the field of biotechnology. His work primarily focuses on decay accelerating factors and their applications in therapeutic settings.
Latest Patents
Among his latest patents is the invention related to decay accelerating factor (DAF) and nucleic acid encoding it. This patent describes novel fusions of a GPI signal domain and a polypeptide heterologous to the GPI signal domain donor polypeptide for industrial use. The therapeutic administration of the GPI-linked product of these fusions enables the targeting of biological activity to cell membrane surfaces. Another significant patent involves nucleic acids encoding decay accelerating factor, as well as vectors and cells that comprise such nucleic acids. This application also discusses the preparation of DAF in recombinant cell culture, particularly focusing on the large-scale manufacture of DAF suitable for pharmaceutical or diagnostic use.
Career Highlights
Michael A. Davitz has had a distinguished career, working with prominent organizations such as Genentech, Inc. and New York University. His experience in these institutions has allowed him to advance his research and contribute significantly to the field of biotechnology.
Collaborations
Throughout his career, Davitz has collaborated with esteemed colleagues, including Ingrid W. Caras and Victor N. Nussenzweig. These collaborations have further enriched his research and innovations.
Conclusion
Michael A. Davitz's work in the field of biotechnology, particularly in the area of decay accelerating factors, showcases his innovative spirit and dedication to advancing medical science. His patents and collaborations highlight his significant contributions to the industry.